12
Dec
Dec
Researchers from the College of Pennsylvania’s Abramson Most cancers Heart offered preliminary outcomes of an ongoing Section I medical trial demonstrating profitable re-treatment with CAR T cell remedy for sufferers whose cancers relapsed after earlier CAR T remedy on the 2022 American Society of Hematology (ASH) Annual Assembly (Summary 2016). CAR T therapies have revolutionized […]